Kuantum Papers Ltd

- No specific mention of current or future debt or equity fundraising in the transcript. - The company is undertaking a major capital expenditure (CAPEX) of Rs.735 crores for capacity upgrades and new specialty paper lines. - Till date, Rs.400 crores of the CAPEX has already been spent. - The entire CAPEX is expected to be completed by June 2026. - No explicit reference to raising funds through debt or equity to finance this CAPEX during the call. - The focus appears on internal investment and phased machine upgrades rather than external fundraising.

- Kuantum Papers has a total capex plan of Rs. 735 crores. - As of now, Rs. 400 crores has already been spent on this capex. - The capex includes upgrading paper machines (PMs) and installing a coating plant for specialty grades. - PM4 upgrade was completed in June 2025, improving productivity and efficiency. - Upgrades on other machines (PM1, PM2, PM3) are ongoing, expected to complete by March 2026. - The coating plant (offline) for manufacturing flexible food wrapping papers and specialty grades is planned to come on stream by financial year-end 2026 or latest next financial year. - The capex is focused on capacity expansion, quality improvement, and diversification into higher-value writing, printing, and specialty paper grades. - Project Nirman, an Industry 4.0 and AI-driven digital transformation, is progressing to enhance productivity and cost efficiency.

- Kuantum Papers plans to complete major machine upgrades by March 2026, with full impact expected in FY 26-27, supporting increased production and efficiency. - Specialty paper share targeted to rise from 20% to about 30% by end of next financial year, driven by new coating plant enabling specialty grades expansion. - Paper machine 4 capacity to increase from ~275 to 315-325 tons/day; other machines also scheduled for capacity upgrades, boosting total output. - Anticipated price rise post-Diwali (October 2025) due to lean Q2 season ending and early government tenders easing market pressure. - Growth supported by rising demand for sustainable, agro-based papers, food-grade wrapping papers, and flexible packaging grades. - Tissue manufacturing planned as a future growth area, aligning with fast (~20% annual) industry expansion. Overall, Kuantum expects sustainable volume and revenue growth driven by capacity expansions, product mix upgradation, and favorable market trends.

- Kuantum Papers aims to increase specialty paper contribution from 20% to 30% by end of FY27, focusing on higher value grades including flexible food wrapping papers (Page 9). - Major capacity upgrades underway: PM4 increased from ~275 to 315-325 tons/day; PM1, PM2, and PM3 also being upgraded by March 2026, boosting total production (Page 9). - Full benefits of these capacity expansions and specialty product upgradation expected to reflect in FY27 earnings (Page 5). - Planned CAPEX of Rs.735 crore, with Rs.400 crore already spent; full operations with upgraded machines expected by June 2026 (Page 5). - Stable to slight price improvements expected post Q2 lean season; price pressures due to imports may ease if anti-dumping measures succeed (Pages 8, 4). - Operational efficiencies and new coating plant installation to improve margins and support specialty grade growth (Pages 4, 9). - Overall, a trajectory of volume growth, premium mix improvement, and margin expansion is anticipated in medium term.

The transcript does not provide specific details on the current or expected orderbook or pending orders for Kuantum Papers Limited. - There is no direct mention of the orderbook status, pending orders, or future order inflows in the Q1 FY26 earnings call. - Discussions primarily focus on production capacity, specialty grades, pricing trends, market segmentation, and ongoing CAPEX/upgradation plans. - The company highlights market presence across India and growth plans in specialty papers and tissue manufacturing but does not quantify order backlog. - Planned capacity expansions are expected to come on stream by June 2026, with positive business impact anticipated in FY27. For precise information on the orderbook, contacting the company's investor relations department would be advisable.